InsiderClue
Insiders · Profile

Mammen Mathai

Director at 10x Genomics · SVP, Research & Early Clin Dev at Innoviva. Filing since 1 Sep 2010. CIK 0001421050

TXG 10x Genomics, Inc. Director · 1 trade INVA Innoviva, Inc. SVP, Research & Early Clin Dev · 8 trades
Company
Date
Role
Action
Shares
Amount
Of holding
TXG 10x Genomics, Inc.
11 May 2023
Director
Sold at will
33,000
$1.74M
16.3%
INVA Innoviva, Inc.
14 Feb 2014
SVP, Research & Early Clin Dev
Sold, plan not stated
35,000
$1.38M
15.8%
INVA Innoviva, Inc.
30 Jul 2013
SVP, Research & Early Clin Dev
Sold, plan not stated
7,000
$255.57K
3.2%
INVA Innoviva, Inc.
30 Apr 2013
SVP, Research & Early Clin Dev
Sold, plan not stated
7,000
$236.16K
3.3%
INVA Innoviva, Inc.
20 Feb 2013
SVP, Research & Early Clin Dev
Sold, plan not stated
7,000
$154.98K
3.2%
INVA Innoviva, Inc.
2 Nov 2012
SVP, Research & Early Clin Dev
Sold, plan not stated
7,000
$150.16K
3.3%
INVA Innoviva, Inc.
13 Aug 2012
SVP, Research & Early Clin Dev
Sold, plan not stated
25,000
$643.46K
10.5%
INVA Innoviva, Inc.
18 Feb 2011
SVP, Research & Early Clin Dev
Sold, plan not stated
3,701
$85.57K
1.4%
INVA Innoviva, Inc.
1 Sep 2010
SVP, Research & Early Clin Dev
Sold, plan not stated
4,416
$56.70K
3.6%
9 decisions on file.